PacBio Developing Chip Technology for Highly Multiplexed 'V2' Sequencers; Launch Planned for 2014

Starting in 2014, PacBio plans to launch two FDA-certified systems that are based on the new technology: a high-throughput instrument that will be able to sequence a human genome with several-fold coverage in 15 minutes or less; and a sub-$50,000 point-of-care instrument that will be "the size of a copier" and have a lower throughput.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.